K-numberK250426
Device nameAmulet™ Steerable Delivery Sheath
ApplicantABBOTT MEDICAL
Product codeDQY
Device classClass II
Decision dateApr 25, 2025
DecisionSubstantially Equivalent
Regulation870.1250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Amulet™ Steerable Delivery Sheath is a 14F catheter delivery device designed to provide a pathway for delivering the Amplatzer™ Amulet™ Left Atrial Appendage Occluder. It features a deflectable distal tip that can bend 120° clockwise and includes a dilator, radiopaque body for fluoroscopic visibility, and a marker band for positioning guidance during cardiac procedures.

Technological characteristics

The device incorporates a deflectable sheath with dual curve geometry in two dimensions creating three-dimensional positioning, includes a dilator for tissue penetration, and features a 14F flush adapter. The key difference from the predicate is the in-process solvent used to prepare the distal tip PEBAX extrusions surface, along with newly implemented tip bond tensile specifications and in-process tensile test methods that align with existing product requirements.

Test standards cited

ISO 10993-1 (biocompatibility evaluation), ISO 14971 (risk management), ASTM F2475 (biocompatibility testing), ISO 11135 (sterilization via ethylene oxide gas), and FDA Guidance on International Standard ISO 10993-1 for biological evaluation of medical devices.

Substantial equivalence argument

The subject device shares substantially equivalent design, function, packaging, sterilization process, materials, fundamental technology, and operating principles with the predicate Amulet Steerable Delivery Sheath (K232690). Although the surface preparation solvent for PEBAX extrusions differs, biocompatibility evaluation determined this change presents negligible risk to the established safety profile. Performance qualification testing confirmed the device met specifications for occluder retrieval, sheath integrity, and tensile bonds; sterilization and microbiology assessment found no increased risk, and no new materials were introduced, maintaining identical patient contact types and durations.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →